why choose us

First received: August 25, 2022

Clinical Trial: Intrathecal Chemoprophylaxis to Prevent Neurotoxicity Associated With Blinatumomab Therapy for Acute Lymphoblastic Leukemia

Study Status: Completed

Recruit Status: RECRUITING

Condition: Acute Lymphoblastic Leukemia

Study Type: INTERVENTIONAL


Official Title: Intrathecal Chemoprophylaxis to Prevent Neurotoxicity Associated With Blinatumomab Therapy for Acute Lymphoblastic Leukemia

Brief Summary: Changing the schedule of intrathecal chemotherapy to be given before and during blinatumomab will maintain the anti-leukemic effects of this drug while at the same time adding the benefit of limiting the neurotoxicity associated with cytokine release.

Read more